| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 3.103 | 23.144 | 30.745 | 50.022 | 72.014 | 93.759 | 103.696 | 119.043 | 141.704 | 138.620 |
| Total Income - EUR | 3.103 | 23.144 | 30.745 | 50.023 | 72.015 | 93.759 | 103.696 | 119.044 | 153.229 | 185.133 |
| Total Expenses - EUR | 1.492 | 13.762 | 15.399 | 13.890 | 11.020 | 11.580 | 15.491 | 14.234 | 30.544 | 76.358 |
| Gross Profit/Loss - EUR | 1.612 | 9.383 | 15.345 | 36.133 | 60.995 | 82.179 | 88.206 | 104.810 | 122.685 | 108.776 |
| Net Profit/Loss - EUR | 1.519 | 8.688 | 14.423 | 34.633 | 58.835 | 79.628 | 85.095 | 101.914 | 121.268 | 103.222 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Medflomar Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 207 | 0 | 0 | 0 | 812 | 30.801 | 26.764 | 24.431 | 72.222 | 17.429 |
| Current Assets | 1.474 | 8.960 | 14.721 | 35.181 | 59.975 | 75.356 | 103.920 | 100.575 | 92.787 | 170.361 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 589 | 0 | 26.780 | 42.759 | 57.453 | 85.086 | 72.782 | 1.894 | 6.918 |
| Cash | 1.474 | 8.371 | 14.721 | 8.401 | 17.216 | 17.903 | 18.834 | 27.793 | 90.893 | 163.443 |
| Shareholders Funds | 1.564 | 8.744 | 14.482 | 34.687 | 59.133 | 79.754 | 85.252 | 102.264 | 121.332 | 103.456 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 117 | 216 | 239 | 494 | 1.653 | 26.403 | 45.431 | 22.742 | 43.677 | 84.334 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Medflomar Srl